| Cyclodextrin‐derived ROS‐generating nanomedicine with pH‐modulated degradability to enhance tumor ferroptosis therapy and chemotherapy M Xu, H Zha, R Han, Y Cheng, J Chen, L Yue, R Wang, Y Zheng Small 18 (20), 2200330, 2022 | 34 | 2022 |
| Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity Y Cheng, Y Zhao, Y Zheng Chinese medicine 16 (1), 114, 2021 | 33 | 2021 |
| Predicting liposome formulations by the integrated machine learning and molecular modeling approaches R Han, Z Ye, Y Zhang, Y Cheng, Y Zheng, D Ouyang Asian Journal of Pharmaceutical Sciences 18 (3), 100811, 2023 | 11 | 2023 |
| Particle Integrity and Size Effect on the Journey of Polymeric Nanocarriers in Zebrafish Model and the Correlation with Mice J Tao, Z Wei, M Xu, L Xi, Y Cheng, SMY Lee, W Ge, Y Zheng Small 17 (43), 2103584, 2021 | 9 | 2021 |
| Size-dependent macrophage-targeting of mannose-modified rosiglitazone liposomes to alleviate inflammatory bowel disease E Wang, R Han, M Wu, Y He, Y Cheng, J Lu, Y Zheng Chinese Chemical Letters 35 (1), 108361, 2024 | 6 | 2024 |
| Shape and shear stress impact on the toxicity of mesoporous silica nanoparticles: in vitro and in vivo evidence Y Cheng, J Tao, Y Zhang, L Xi, R Han, M Xu, SMY Lee, W Ge, Y Gan, ... Molecular Pharmaceutics 20 (6), 3187-3201, 2023 | 5 | 2023 |
| Apoptosis-Sensing Xenograft Zebrafish Tumor Model for Anticancer Evaluation of Redox-Responsive Cross-Linked Pluronic Micelles J Tao, Z Wei, Y Cheng, M Xu, Q Li, SMY Lee, W Ge, KQ Luo, X Wang, ... ACS Applied Materials & Interfaces 14 (35), 39775-39786, 2022 | 2 | 2022 |
